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ABSTRACT
Objective: We sought to determine the clinical and laboratory features of trichomonas vaginitis (TV) in a
chronic vaginitis clinic.
Methods: We studied 45 women with symptomatic TV attending a specialty chronic vaginitis clinic.
These patients were older than the usual symptomatic patients with TV. They frequently described unusual
chronicity of symptoms, half being referred because of clinical resistance and the other half referred because
of chronic vaginitis of unknown etiology.
Results: In spite of the chronicity of infection, the signs and symptoms of florid inflammation were still
evident and high numbers of polymorphonuclear leukocytes and parasitic load were present.
Conclusions: A longstanding infection, especially if previously untreated, invariably responded to
conventional nitroimidazole therapy. In .addition, the majority of patients seen with clinical resistance
to the conventional doses of metronidazole responded to high-dose oral metronidazole therapy. Unsus-
pected TV should always be considered in low-risk patients with chronic vulvovaginal symptoms.
(C) 1996 Wiley-Liss, Inc.
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richomoniasis (TV) is transmitted almost exclu-
sively by sexual contact, representing a major
health problem, especially for women. Since the
first description ofTV by Donne in 1836, its clinical
features have been amply studied and critically re-
viewed. 3-6 With TV being a venereal infection, most
studies examining its clinical manifestations have
been carried out in sexually transmitted disease
(STD) clinics.
4-6 STD clinics serve a selected popu-
lation characterized by low socioeconomic status
and a heavy burden of associated medical morbid-
ity. Much less is known about the presentation of
TV in other clinical settings. The findings reported
here encompass the clinical and laboratory features
of TV in a chronic vaginitis clinic.
MATERIALS AND METHODS
The Wayne State University Vaginitis Clinic is a
predominantly physician-referred service with ap-
proximately 1,000 patient visits per year. The clini-
cal records were reviewed for patients withTV diag-
nosed by microscopy or culture from January 1990
through May 1994. Detailed medical histories were
obtained from all patients, followed by general and
pelvic examinations. After a careful vaginal and cer-
vical examination using a speculum was carried out,
vaginal swab specimens were obtained from both
fornices and the mid-third of the vagina for a mea-
surement of pH and saline and 10% potassium-
hydroxide microscopic examination. Additional va-
ginal fluid samples were obtained for yeast and
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Trichomonas vaginalis culture on Sabouraud’s and
Diamond’s media, respectively. Cervical samples
for Neisseria gonorrhoeae and Chlamydia trachomatis
cultures were obtained if these infections were
judged clinically relevant.
Case Definition
Acute TV was defined as the presence ofsymptoms
and signs compatible with vulvovaginitis -<28 days
and by the documentation of trichomonads on sa-
line, wet-mount microscopy, or culture. Other diag-
nostic criteria included an increase in polymorpho-
nuclear leukocytes (PMNs) in the vaginal secretions
as detected by light microscopy (PMNs to squa-
mous epithelial cells in a ratio of> 1:1) and a vaginal
pH of >4.5. ChronicTV included the same diagnos-
tic criteria except that the duration of symptoms
exceeded month. A mixed infection; e.g., TV
and candidiasis, was diagnosed ifCandida organisms
were visualized on microscopy and confirmed by
culture in addition to the presence of Trichomonas.
Concomitant bacterial vaginosis required the addi-
tional presence of clue cells on microscopy.
All male partners of the patients with both acute
and chronic TV were given 2.0-g single-dose
courses of metronidazole, regardless of previous
anti-protozoal therapy.
RESULTS
Forty-eight episodes of TV were diagnosed in 45
women at the Wayne State University Vaginitis
Clinic during the study period. Three patients had
2 episodes of TV each. During the same period,
1,741 patients were seen at the vaginitis clinic. The
45 women with TV accounted for 2.5% of all pa-
tients seen and 4% of patients in whom a definite
pathologic diagnosis was established. The most
common diagnoses in the clinic were vulvovaginal
candidiasis, found in 16% of the women, and bacte-
rial vaginosis, observed in 12% of the patients (un-
published observations).
TV was diagnosed on the initial visit to the clinic
in 29 of the 45 (64.4%) identified patients. Fifteen
of these patients were referred with the diagnosis of
TV unresponsive to conventional antitrichomonal
therapy. The remaining 14 women in this group
were referred because of undiagnosed persistent
vaginal symptoms. In 16 additional patients (total-
ing 19 episodes), acute TV was diagnosed while
the patient was being followed at the clinic for other
categories of vulvovaginitis.
A mixed infection, namely, concomitant TV and
bacterial vaginosis orTV and vulvovaginal candidia-
sis, was observed in 14 (34%) patients or 15 (31%)
episodes. In 11 patients (73%) with mixed episodes,
TV was associated with bacterial vaginosis; in 3
(20%) episodes, the concomitant infections in-
cluded bacterial vaginosis and vulvovaginal candidi-
asis; and in (7%) episode, vulvovaginal candidiasis
was diagnosed concurrently. In an additional 3 epi-
sodes, yeasts were noted on culture but were not
seen on the microscopic examination. Seven (47%)
mixed infections were diagnosed on the first visit
to the clinic (representing 24% of infections diag-
nosed on that occasion), and the remaining 8 epi-
sodes were observed on subsequent visits (42% of
infections detected in returning patients). Most of
the uncomplicated TV (21 of 30 or 70%) were diag-
nosed on the first visit.
The demographic data of the population studied
are shown in Table 1. The mean age was similar
in both TV subgroups. More than three-quarters of
the patients with TV were black. Only a minority
of the TV patients were married at the time of di-
agnosis.
Eighty-nine percent of the TV patients used
some form of contraception; the single, most pre-
ferred device was the condom (28%), followed by
the contraceptive pill (26%). About one-third of the
women with TV relied on sterilization (hysterec-
tomy, tubal ligation, menopause, or vasectomy) for
contraception. Of the women with TV, 92.5% had
had at least sexual partner in the year preceding
the diagnosis. The frequency of sexual activity in
the TV group was variable: 54% of the patients
had coitus <once per week, while 21.6% had 2
encounters per week and 19% had intercourse >3
times per week. A low frequency (<once per week)
of intercourse was reported more often by women
diagnosed on initial visits than in patients diagnosed
on subsequent visits (74% vs. 25%).
A history of TV was obtained in 19 (42%) pa-
tients, including 3 patients in whom previous epi-
sodes of TV were diagnosed at the clinic. Other
past genital infections were frequent: 35% reported
past candidiasis or bacterial vaginosis; 11% had had
an STD; and 25% had had both.
The prevalence of vaginitis-associated symp-
toms in the study population is shown in Table
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TABLE I. Demographic data on patients with TV
All patients
(N 45)
Patients diagnosed Patients diagnosed on
on first visit subsequent visits
(N 29) (N 16)
"chronic acute"
Mean age (range) (years) 36 (18-68) 34.9 (18-68) 36. (21-52)
White/black (% black) 9/34 (79%) 6/21 (78%) 3/13 (85%)
Married at diagnosis (%) 8/45 (18%) 3/29 (10%) 5/16 (26%)
Unemployed (%) 4/39 (10%) 3/28 (I I%) I/I (9%)
TABLE 2. Frequency of symptoms in patients with TV
All episodes
(N 48)
Episodes diagnosed Episodes diagnosed
on first visit on subsequent visits
(N 29) (N 19)
"chronic acute"
Duration
<-4 weeks 16/43 (37%)
->4 weeks 27/43 (63%)
Odor 32/42 (81%)
Itching 36/45 (80%)
Irritation 7/36 (19%)
Burning 15/41 (37%)
Dyspareunia 8/20 (40%)
1/27 (4%) 15/16 (93%)
26/27 (96%) 1/16 (7%)
18/23 (78%) 16/19 (84%)
20/27 (74%) 16/18 (89%)
2. Since women attend vaginitis clinics primarily
because of symptoms, all our patients were symp-
tomatic. Most women (63%) had prolonged or
chronic symptoms (>4 weeks). Chronic symptoms
were particularly evident in patients diagnosed with
TV on the first visit to the clinic (96%), while only
7% of the episodes observed on subsequent visits
to the clinic were chronic. Eight patients, all with
uncomplicated TV and chronic symptoms, had not
had sexual contact for more than 6 months (4 pa-
tients for -> year and patient for 3 years). In the
chronic cases, the prolonged duration of symptoms
was caused by the lack of an appropriate diagnosis
and, hence, therapy (14 episodes) or by a nonre-
sponse to the conventional treatment (15 episodes).
Malodor and itching, the most common symp-
toms, were reported as often in chronic as in acute
infections, even after the exclusion of mixed epi-
sodes (78% and 84%, respectively, for odor; 74%
and 89%, respectively, for itching). Irritation, burn-
ing, and dyspareunia, which were less frequently
described, were not further analyzed because of
the small numbers. The prevalence of the physical
findings in our patients with TV is described in
Table 3. An abnormal vaginal discharge was ob-
served in all episodes. Most patients had mild dis-
charges, with no difference observed between
chronic and acute infections, even after the exclu-
sion of mixed infections. The color of the discharge
was yellow or yellow-green in approximately half
of the episodes, while, in the remaining cases, it
was white. A yellow discharge was as common in
chronic (55%) as in acute episodes (50%). The dis-
charge was described as frothy in only 4 instances
and cheese-like in another 2 patients. The signs
of vulvar inflammation (erythema edema), which
were observed in 70% of the episodes, were some-
what more common in chronic than in acute infec-
tions, even after the elimination of mixed cases
(77% vs. 59%). Vaginal erythema (___edema) was
noted in 90% of episodes; all 5 cases with intense
inflammation (erythema + edema) had chronic
courses. Cervical involvement was less common
(22%), and colpitis macularis was observed in a sin-
gle case with an acute presentation (3%).
The laboratory findings associated with TV arc
presented in Table 4. An elevated pH (>4.5) was
measured in all but case, while a positive amine
test was detected in three-quarters of the episodes.
Leukocyte increase and abnormal bacterial flora
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TABLE 3. Frequency of various signs in patients with TV
All episodes
(N 48)
Episodes diagnosed Episodes diagnosed
on first visit on subsequent visits
(N 29) (N 19)
"chronic" "acute"
Discharge
+ 31/48 (64%)
+ + 5/48 ( 0%)
+ + + 1/48 (24%)
Color
Yellow-green 19/36 (53%)
Vulva
Normal 13/43 (30%)
Erythema 19/43 (44%)
+ Edema 1/43 (26%)
Vagina
Normal 4/41 (10%)
Erythema 32/41 (78%)
+ Edema 5/41 (12%)
Cervix
Normal 25/32 (78%)
Erythema 7/32 (22%)
18/28 (64%) 12/19 (63%)
4/28 (14%) 1/19 (5%)
5/28 (18%) 6/19 (32%)
12/22 (55%) 7/14 (50%)
6/26 (23%) 7/17 (41%)
12/26 (46%) 7/17 (41%)
8/26 (31%) 3/17 (18%)
(loss of the dominant lactobacillus morphotype)
were observed on microscopic examination in the
majority of infections. In only 2 instances was T.
vaginalis detected by culture after a negative wet-
mount examination. It appears that, with the excep-
tion of the amine test, the laboratory findings were
as pronounced in chronic as in acute infections (after
the exclusion of mixed infections): a pH of >5 was
observed in 83% of the chronic episodes vs. 69%
of the acute ones; increased numbers of leukocytes
and T. vaginalis organisms were noted as often in
chronic protracted TV as in acute TV.
Four different regimens of metronidazole were
used in the treatment of TV: 2.0-g single-dose (1
case); 7-day regimen of metronidazole, 500 mg b.i.d.
(28 cases); and 14-day regimen with (9 cases) or
without (2 cases) vaginal metronidazole. In 8 epi-
sodes, there was insufficient information on the dos-
ing modality present in the chart. Most of the long
courses (14 days) were prescribed for patients re-
ferred because of a history of failure of the standard
regimens. The only patient with an acute presenta-
tion, who received a prolonged course of oral metro-
nidazole, had been successfully treated at the clinic
2 years earlier forTV with a laboratory-proven resis-
tant organism and failed to respond to a standard
regimen given elsewhere for the present episode
(see illustrative case 1). The 7-day metronidazole
regimen was equally used for chronic and acute
episodes. Two patients successfully responded to
high-dose (>2.0 g/day 7-day regimens). Both of
these patients had been referred to the clinic be-
cause of failure to respond to multiple courses of
metronidazole. Two patients had particularly stub-
born infections. In case (illustrative case 2), no
response was noted after several courses of metroni-
dazole, while a course oftinidazole was immediately
successful. In the other case (illustrative case 3),
the organism demonstrated in vitro resistance to
metronidazole. This patient failed to respond to
several courses of the drug given over 18 months,
until she was lost to follow-up.
ILLUSTRATIVE CASES
Case
A 21-year-old single woman was first seen in the
clinic in December 1990 after having been treated
by several physicians over a period of 12 months
for resistant TV. Her complaints consisted of mal-
odorous discharge, itching, and burning. She had
abstained from sexual intercourse since her symp-
toms began. The patient’s other medical problem
was epilepsy for which she had been taking pheno-
barbital, phenytoin, and sodium valproate. The
vulva, vagina, and cervix appeared intensely ery-
thematous, and a yellow-green discharge was noted.
The pH of the vaginal fluid was 6. On wet-mount
examination, an abundance ofPMNs and trichomo-
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TABLE 4. Frequency of laboratory findings in patients with TV
All episodes
(N 48)
Episodes diagnosed Episodes diagnosed
on first visit on subsequent visits
(N 29) (N 19)
"chronic" "acute"
pH
<4.5 1/45 (2%) 1/29 (3%) 0
4.5-5 9/45 (20%) 4/29 (14%) 5/16 (31%)
>5 35/45 (78%) 24/29 (83%) 11/16 (69%)
Amine test
Positive 30/40 (75%) 17/25 (68%) 12/15 (80%)
WBCs
6/40 (15%) 2/29 (7%) 4/11 (36%)
+ 34/40 (85%) 27/29 (93%) 7/11 (64%)
Bacterial flora
Normal 6/33 (18%) 6/24 (25%) 0/9 (0%)
Abnormal 24/33 (73%) 16/24 (67%) 8/9 (89%)
Mixed 3/33 (9%) 2/24 (8%) I/9 (I I%)
Trichomonads 46/48 (96%) 27/29 (93%) 19/19 (100%)
aSaline microscopy- ratio of PMNs: epithelial cell >1.0.
hAs determined on Gram’s stain.
cVisualized on saline microscopy.
nads were observed, while no clue cells or yeasts
were present. Metronidazole, 250 mg t.i.d., was pre-
scribed for 10 days. The patient improved while on
therapy, but her symptoms recurred 2 weeks later
when trichomonads were again seen on the wet-
mount examination. Metronidazole susceptibility
testing of the initial isolate revealed a minimum
lethal concentration of 80 Ixg/ml. Two subsequent
courses of high-dose oral metronidazole (500 mg
b.i.d, for 14 days together with 500 mg b.i.d, vagi-
nally for 7 days) also failed to eradicate the infection.
The infection was finally cured by the oral adminis-
tration of metronidazole, 500 mg q.i.d., over 2
weeks, accompanied by local vaginal metronidazole
therapy. She was subsequently seen at 3 and 6
months with no evidence of symptomatic or para-
sitic recurrence.
Comment." The failure to eradicate an infection
with the standard dose of oral metronidazole can
be attributed to the relative in vitro resistance of
the parasite. However, another factor that might
have been contributory was the patient’s phenobar-
bital therapy, as the drug is reported to alter metro-
nidazole hepatic metabolism (see Discussion).
Case 2
A 40-year-old married woman presented with a 3-
month history of purulent discharge, itching, and
soreness that was diagnosed as TV. She had pre-
viously failed to respond to 2 courses of metronida-
zole, 500 mg q.i.d, for 14 days. On her examination,
intense vulvovaginal inflammation and an abnormal
discharge were noted. The vaginal pH was >6 and
the amine test was negative. Numerous PMNs and
trichomonads were observed on the wet-mount ex-
amination. The patient was treated with metronida-
zole orally, 1.0 g q.i.d., and vaginal tablets, 500 mg
b.i.d, for 14 days (a total dose of 70 g). One week
after the completion of treatment, her symptoms
recurred. Parasites were again seen on the micro-
scopic examination. A hospital admission for intra-
venous (IV) metronidazole therapy was refused by
the patient. Finally, tinidazole, 2.0 g orally for 14
days, was prescribed. Her response to tinidazole
was dramatic and her follow-up examinations were
normal at and 3 months.
Comment: In this case, TV persisted despite mul-
tiple courses ofmetronidazole, including a combina-
tion of high-dose oral and intravaginal administra-
tion. In vitro susceptibility studies were not
performed. A prompt response was observed to tini-
dazole, another 5-nitroimidazole.
Case 3
A 24-year-old single woman was referred to the
clinic for recurrent TV that had been present for
year. She had received at least 6 courses of metroni-
dazole, 500 mg b.i.d, for 7-14 days. The patient had
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not been sexually active during the entire period
because ofdyspareunia. When seen at the clinic, she
complained of a green-yellow discharge, mal0dor,
burning, and itching. On her examination, the vulva
and vagina were erythematous and edematous. Ab-
normal secretions were observed, with a pH of >6
and a negative amine test. The wet-mount examina-
tion revealed an abundance ofPMNs and trichomo-
nads. The patient was started on metronidazole
tablets, 3.0 g/day orally and 1.0 g/day by the
intravaginal route. Because of severe nausea, the
dose of the oral drug was reduced to 2.0 g/day.
After completing a 14-day course, her partner being
treated concomitantly, the clinical and laboratory
findings persisted. The patient was lost to follow-
up and then hospitalized 4 months later, at which
time she continued to have a florid TV. A total of
26.0 g of metronidazole was administered IV over
7 days with no effect on the TV. The minimal
inhibitory concentration (MIC) of the trichomonal
isolate was 265 txg/ml. The patient was last seen at
the clinic in September 1990 and lost to fol’low-up.
Comment." The infection in this case was particu-
larly resistant to modalities of metronidazole ther-
apy, including high-dose IV administration. At the
time, tinidazole therapy was not available.
DISCUSSION
The majority of studies that have examined the
demographic, clinical, and laboratory aspects ofTV
were conducted at STD clinics.4-6 It is not surpris-
ing, therefore, that some of the findings in the pres-
ent investigation, which was conducted in a referral
chronic vaginitis clinic, differ from those pre-
viously reported.
The mean age ofthe patients treated at our clinic
(36 years) was higher than that ofwomen diagnosed
at STD clinics (24 years).
4-6 Most of our patients
were employed, which is probably related to the
socioeconomic level of the population attending our
clinic, with most of the patients belonging to the
middle class. In keeping with previous studies per-
formed in STD clinics in the United States, there
was a high proportion of unmarried patients and a
predominance of black women.4-6 These findings
are in sharp contrast with the characteristics of the
patients with vulvovaginal candidiasis seen on our
referral clinic who are mostly married and white. {7/
Noteworthy, there was a common association of
TV with bacterial vaginosis rather than vulvovaginal
candidiasis. Fouts and Kraus have also noted that
vaginal yeast is detected less frequently with TV.
Finally, in contrast to previous studies of TV in
STD clinics, a higher proportion of our patients
used barrier contraception (28%) compared with
previous reports (<6%). 5’6
Although sporadic cases of persistent TV have
been reported,
8-1 no attempt has been made to
study the clinical and laboratory characteristics of
TV in its more chronic form. In the present study,
chronic TV is best represented by a group of 8
women with prolonged symptoms for at least 6
months (6-36 months). During the symptomatic
period, the patients were not sexually active; ac-
cordingly, reinfection can be ruled out. The pro-
longed reduction of sexual activity or abstinence
in patients with chronic diseases deserves special
attention. In this regard, it should be noted that
dyspareunia was as common in the group of patients
with chronic disease as in those with acute symp-
toms. No significant difference was observed be-
tween the patients with chronic presentations and
those with acute diseases with regard to the symp-
toms and signs with the exception of a tendency
toward more intense vaginal inflammation in some
chronic cases. The most common symptoms among
all our patients were malodorous discharge and itch-
ing, each reported by 80% of the women with either
acute or chronic presentation. This prevalence is
somewhat higher than reported by others. Simi-
larly, vulvar and vaginal erythema was more often
observed in our patients than in those reported pre-
viously.4’6
No difference in laboratory findings was evident
in the patients with acute or chronic TV. Thus,
in spite of chronicity, no loss in infectious load or
reduction in inflammatory reaction was apparent.
Metronidazole has been the drug of choice for
treating trichomonal infections since its introduc-
tion in the 1960s. Therapeutic regimens using oral
metronidazole, 250 mg t.i.d., 500 mg b.i.d, for 7
days, or, more recently, a single 2-g dose, have
shown cure rates of >90%. Based on our limited
experience, it appears that the standard 7-day met-
ronidazole regimen is efficacious in chronic, un-
treated vaginal TV.
Although TV can be refractory to treatment with
metronidazole, true resistance of the organisms to
metronidazole has remained uncommon. Failure to
eradicate T. vaginalis has been attributed to poor
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patient compliance, reinfection by an untreated or
new partner, interference by other organisms, pres-
ent on the vagina, 11,1z possible drug interaction,
13 or
low serum zinc concentrations. 14 A repeat course of
a conventional dose, 7-day regimen or a longer (14-
day) course, together with a correction ofthe failure-
predisposing causes if relevant, should cure the vast
majority of patients with recurrent TV.
True laboratory-documented metronidazole-
resistant T. vagina/is isolates were first described in
the late 1970s and early 1980s. The mechanism of
resistance appears to be related to a deficiency in
the ferredoxin-linked, oxygen-scavenging capacity
which limits the activation of metronidazole by re-
ducing its nitro group.
5 In vitro studies have shown
that mebendazole, furazolidone, and ansomycin are
the most active drugs against metronidazole-resis-
tant trichomonads.
6 Clinical resistance, is initially
treated with an increase in the daily dose (including
IV administration) and duration of treatment. This
approach may be hampered, however, by side and
toxic effects, the frequency and severity of which
are dose-dependent. Although not tested in pro-
spective studies, patients with clinical resistance
also appear to benefit from the concomitant intra-
vaginal administration of metronidazole. Alterna-
tive methods with variable success include systemic
tinidazole, mebendazole, 20% saline douches,
3% acetic-acid douches, intravaginal application of
gentian violet, chlorhexidine, povidone-iodine, hy-
drogen peroxide, nonoxynol-9, nitrofurantoin, and
clotrimazole.
One of our refractory cases responded promptly
to tinidazole after the failure of several courses
of metronidazole (in vitro susceptibility was not
tested), while another patient with true drug
resistance remained unresponsive to multiple high-
dose regimens of metronidazole until she was lost
to follow-up. A true resistance to metronidazole
is, fortunately, rare, and managing patients in-
fected with such strains can be very frustrating.
The large choice of therapeutic substitutes with
limited efficacy clearly indicates the need for
further research to find an effective alternative
treatment.
Clinicians in a referral chronic vaginitis clinic
might be expected to see infrequent cases of clini-
cally resistant TV but should also be aware of the
possibility ofundiagnosed, missed cases ofsuscepti-
ble TV. This report serves to emphasize the fre-
quent chronic nature of this infection when undiag-
nosed, particularly in older, low-risk women,
resulting in considerable morbidity. The failure to
diagnose TV reflected by the substandard use of
available diagnostic methods is regrettable, given
the rapid response of chronic vaginitis to conven-
tional therapy.
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